Marche-PN

Les Sciences, l'Histoire et le PSG

[Marche-PN @MarchePN56]

https://t.co/fuI9bTWDsO

[GeNeuro @GeneuroO]

Congratulations to @PatrickKury and team for their important article showing the effects of HERV-W on #MS-related smoldering neuroinflammation
#smolderingMS #HERVs

https://t.co/7dmrpM2mwC

[Marche-PN @MarchePN56]

Nice presentation by Zuzana Macek-Jilkova of IAB works on the immune status of the liver in HBV infection during the exciting annual meeting of H2020 IP-Cure-B EC project hosted by F Zoulim in Lyon. @IAB_Officiel #ELPA

[IAB @IAB_Officiel]

#Recruitment📢| Interested in #ReproductiveBiology?
The team "Physiology and Pathophysiology of Sperm cells" is offering a Technician Position at the Institute for Advanced Biosciences.
🗓️ Deadline for application: April 30th 2024

More information below 👇

[Marche-PN @MarchePN56]

Le projet IVT-Foie fête sa première année ! Pour un nouveau traitement du cancer du foie avec le soutien de la Région Auvergne Rhône-Alpes et le Cancéropole CLARA associant clinicien, biologiste, ingénieur et industriel.

[Marche-PN @MarchePN56]

Nice presentation on how Hepatitis B virus alters our immunity by Lucile Dumolard (young fellow) at ANRS AC42 meeting ( support of IP-Cure-B)

[European Liver Patients' Association @EuropeLiver]

🌟 Step into the future of healthcare at the High-Level European Meeting on #LiverCancer Prevention! 🌍 ELPA President Marko Korenjak sets the stage for an extraordinary convergence of minds. 🤝 Join the symphony of voices - #policy, #science, and #patient communities uniting to tackle #inequalities in cancer care! 🎤 Let's weave a tapestry of collaboration for #prevention, health #literacy, and elevating the quality of life for #LiverCancer patients and survivors. 🌈 Embrace the journey from early diagnosis to treatment, fueled by the vital spark of funding. 🚀 Together, we champion the transformative power of the EUCancerPlan. Stay tuned for an encore of exciting news! 🎉 #LiverHealth #EUCancerPlan #HealthcareRevolution

MEP @TomislavSokol, EPP, Croatia
MEP @estrella_dura , S&D, Spain
MEP @LjudmilaNovak, EPP, Slovenia
MEP @Ibangarciadb, S&D, Spain
MEP @MonicaSemedoLux, Renew Europe Group, Luxembourg
MEP Radka Mahová, S&D, Czech Republic.

Mr Marco Greco, President of the European Patients'​ Forum (EPF),Italy
Dr. Alessandro Gallina, Policy Manager, (European Public Health Alliance (EPHA),Belgium
Mr Richard Price, Head of Policy, Ms Silvia Romeo, Policy Officer, European Cancer Organisation (ECO),Belgium
Ms Gertrude BUTTIGIEG BUTTIGIEG, Chairperson,Malta Health Network,
Ms Lili Anna Gundelach, Medical and Scientific Project Coordinator, Digestive Cancers Europe (DiCE),

#LiverCancerPrevention #EPmandate #HealthcareInnovation 🔗 #EUCancerPlan #WorldCancerDay #CloseTheCareGap @dice_europe @EPHA_EU @eupatientsforum @CSOGroupEESC @EPPGroup @TheProgressives @RenewEurope @EuropeanCancer @EU_Commission @EC_HERA @EU_Health @EASLnews @ILCAnews @myESMO @IARCWHO @GLOBOCAN_GCO @hans_kluge @WHO_Europe @SKyriakidesEU @EU_Health

[European Liver Patients' Association @EuropeLiver]

ELPA Vice-President Julio Burman at the EASL scientific #LiverCancerSummit 2024, where cutting-edge science meets patient perspectives. Explore the nexus of primary liver tumors, including HCC and biliary tract cancer
Cholangiocarcinoma, examining their links to viral infections, alcohol misuse, and metabolic disorders. Gain insights and tools that can shape the future of patient care and influence policy decisions. Follow for updates and be part of this fascinating journey! #LiverCancerSummit2024 #HealthcareInnovation #WorldCancerDay #WorldCCADay #EUCancerPlan @EASLnews @EASLedu @AleksanderKrag @Marko_Korenjak @MKDmilanM

[Marche-PN @MarchePN56]

@AnneBulin @IAB_Officiel @Inserm Well donne towards future.

[Mathias Heikenwälder @CancerInflam]

Our manuscript on the role of intestinal B-cells in NASH, as well as immunoglobulins in NASH-related fibrosis and HCC is online. Thankful to all collaborators - what a journey - a real team effort! CHECK IT OUT! https://t.co/d89nfSxOGi

[Inserm @Inserm]

#HPV Alors que les données scientifiques sur l’efficacité du #vaccin s’accumulent, la couverture vaccinale reste faible en France. #CanalDétox fait le point sur les effets bénéfiques du #vaccin anti-HPV, chez les garçons comme chez les filles.

➡️https://t.co/fBrubdma1f

[IBENS @IBENS_ENS]

📢Exciting symposium on Epigenetics!
Signaling through chromatin: from molecules to ecosystems. Oct 2-4 2023 in Grenoble
Supported by #IBENS and @embl @cdf1530 @IBS_Grenoble @IAB_Officiel @PSB_Grenoble @EMBLGrenoble @EMBLRome
@EMBLEvents

[Marche-PN @MarchePN56]

Présentation de nos travaux en cours (C. Founier et col) pour un vaccin ARN contre le cancer du foie avec @IAB_Officiel @CHU_Grenoble @CEA_Leti au #ForumCLARA avec le soutien de la Région AuRA @auvergnerhalpes

[Marche-PN @MarchePN56]

A. Millet montre l'importance du métabolisme des macrophages dans les Cancers du colon. #ForumCLARA. @IAB_Officiel @auvergnerhalpes

[Marche-PN @MarchePN56]

A. EMADALI présente ses travaux sur le rôle de Cyclon dans les Cancers au forum CLARA Region AuRA. @IAB_Officiel @CHU_Grenoble @auvergnerhalpes

[Marche-PN @MarchePN56]

Recherche contre les Cancers, anniversaire fête les 4-5 avril à la Région Auvergne-Rhône-Alpes #IAB_Officiel

[AASLD @AASLDtweets]

Register today! 📘

Our understanding of immune tolerance in chronic #hepatitis B has been evolving. This webinar will provide updates in broad perspective, scientific context & clinical implications. https://t.co/Dnmb5aUoMm

#LiverTwitter @Anto_Berto @DrSimonLing @MarkThursz

[Université Grenoble Alpes @UGrenobleAlpes]

#QSRankings2023 🏆// 3 FOIS DANS LE TOP 50 et classée dans 21 disciplines, l'@UGrenobleAlpes progresse encore dans ce #classement de renom qui évalue la qualité scientifique et la réputation de 1594 institutions dans le monde ! 👏👏à nos laboratoires !
🧐https://t.co/Yn4dtPhEef

[Marche-PN @MarchePN56]

Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation https://t.co/2qv7qhlji8